All GLG News Analyses Filed Under: Infectious Disease
Posted December 5, 2007
BHARAT BIOTECH LAUNCHES TWO NEW VACCINES IN INDIA (Bio-Hib and Comvac4-HB vaccines)
Analysis of: BHARAT BIOTECH LAUNCHES TWO NEW VACCINES IN INDIA (Bio-Hib and Comvac4-HB vaccines) | www.therapeuticsdaily.com
Author: GLG Member Program Contributor
Analysis of: BHARAT BIOTECH LAUNCHES TWO NEW VACCINES IN INDIA (Bio-Hib and Comvac4-HB vaccines) | www.therapeuticsdaily.com
Author: GLG Member Program Contributor
Indian companies are expanding beyond generics.
Posted December 3, 2007
BHARAT BIOTECH LAUNCHES TWO NEW VACCINES IN INDIA (Bio-Hib and Comvac4-HB vaccines)
Analysis of: BHARAT BIOTECH LAUNCHES TWO NEW VACCINES IN INDIA (Bio-Hib and Comvac4-HB vaccines) | www.therapeuticsdaily.com
Author: GLG Member Program Contributor
Analysis of: BHARAT BIOTECH LAUNCHES TWO NEW VACCINES IN INDIA (Bio-Hib and Comvac4-HB vaccines) | www.therapeuticsdaily.com
Author: GLG Member Program Contributor
India and China are set to become major players in the vaccine market Already India vaccine manufacturers have moved from simple single component vaccines to more complex conjugates and combinations. In the next 10 years India and China will become global vaccine suppliers.
Posted December 3, 2007
Meridian Bioscience Receives FDA Clearance For Two New Rapid Tests For The Detection Of Influenza And Respiratory Syncytial Virus
Analysis of: Meridian Bioscience Receives FDA Clearance For Two New Rapid Tests For The Detection Of Influenza And Respiratory Syncytial Virus | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Analysis of: Meridian Bioscience Receives FDA Clearance For Two New Rapid Tests For The Detection Of Influenza And Respiratory Syncytial Virus | www.medicalnewstoday.com
Author: GLG Member Program Contributor
It is nice to know the causative organism in a sick child, but the utility of this test is limited by the lack of specific therapies once the diagnosis is made.
Posted November 30, 2007
Meridian Bioscience Receives FDA Clearance For Two New Rapid Tests For The Detection Of Influenza And Respiratory Syncytial Virus
Analysis of: Meridian Bioscience Receives FDA Clearance For Two New Rapid Tests For The Detection Of Influenza And Respiratory Syncytial Virus | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Analysis of: Meridian Bioscience Receives FDA Clearance For Two New Rapid Tests For The Detection Of Influenza And Respiratory Syncytial Virus | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Meridian's new RSV and Influenza A/B testing should provide new weapons for pediatricians during the upcoming flu and upper respiratory infection season.
Posted November 20, 2007
New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis
Analysis of: New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis | www.pipelinereview.com
Author: GLG Member Program Contributor
Analysis of: New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis | www.pipelinereview.com
Author: GLG Member Program Contributor
Novartis should be applauded for completing the earliest stages of a conjugated meningococcal vaccine for infants and young toddlers. However, it is conceivable that Novartis' Menveo may be cannibalized in the market by sanofi's Menactra. Menactra is an already FDA-approved conjugated meningococcal...
Posted November 20, 2007
New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis
Analysis of: New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis | www.pipelinereview.com
Author: GLG Member Program Contributor
Analysis of: New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis | www.pipelinereview.com
Author: GLG Member Program Contributor
I formerly worked at Pasteur Merieux Connaught and have quite a bit of experience with meningococcal meningitis vaccines. The largest number of cases occur in teenagers and young adults, the second highest group is the pediatric population. This is a deadly disease that can spread quickly among populations...
Posted November 20, 2007
New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis
Analysis of: New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis | www.pipelinereview.com
Author: GLG Member Program Contributor
Analysis of: New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis | www.pipelinereview.com
Author: GLG Member Program Contributor
Meningococcal meningitis is the remaining major bacterial meningitis for which an effective vaccine has not been available for infants and children younger than 10 years of age. this study suggests that infants will no longer be lacking protection against this devastating illness.
Posted November 19, 2007
PegIntron and Rebetol Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
Analysis of: PegIntron and Rebetol Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Analysis of: PegIntron and Rebetol Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Combination therapy with Peg IFN and Ribanirin showed better therapeutic outcome. This fact is well known.
Posted November 16, 2007
FDA Approves MedImmune's Refrigerated Formulation of FluMist
Analysis of: FDA Approves MedImmune's Refrigerated Formulation of FluMist | phx.corporate-ir.net
Author: GLG Member Program Contributor
Analysis of: FDA Approves MedImmune's Refrigerated Formulation of FluMist | phx.corporate-ir.net
Author: GLG Member Program Contributor
While the need to keep FluMist frozen was a mild hassle, the cost and reimbursement issues are the major factor blocking widespread use.
Posted November 16, 2007
Wyeth Salutes World Health Organization Call To Action To Combat Pneumococcal Disease
Analysis of: Wyeth Salutes World Health Organization Call To Action To Combat Pneumococcal Disease | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Previous
Page :
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next61 to
70
of 210Analysis of: Wyeth Salutes World Health Organization Call To Action To Combat Pneumococcal Disease | www.medicalnewstoday.com
Author: GLG Member Program Contributor
The use of Prevnar has reduced the incidence of invasive pneumococcal disease in the US by 99%. This benefit will be even more important to children in underdeveloped areas of the world where the disease is much more devastating and prevalent due to underlying nutritional issues and poor public health...
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler
www.investor.jnj.com
Longer Lashes in a Tube? Maybe Not
www.nytimes.com
Medicare fees to doctors fall Tuesday
news.yahoo.com
Doctors Say Medication Is Overused in Dementia
www.nytimes.com
Why anaesthetics can make the pain worse
www.newscientist.com
An illegal use of Lumigan, now legal?
July 3, 2008
How are we to pay for computers with a 10% drop in Medicare fees?
June 30, 2008
Obesity: Higher Healthcare Costs, Lower Productivity
June 26, 2008
Best acne care product I've seen.
June 25, 2008
Jeff is in accounting not a healthcare provider.
June 23, 2008

